BREAKING NEWS: Gentell to Become One of North America’s Largest Wound Care Dressing Manufacturers with Acquisition of Integra

David Navazio, President and CEO of Gentell, announces the purchase of certain traditional and advanced wound care products and dressings from Integra LifeSciences

Injuries won’t wait for supply chain issues. Gentell made this purchase to strengthen its global ‘platform for growth’ strategy and improve quality and care for the tens of thousands of patients we serve.”

— David Navazio, President and CEO of Gentell


David Navazio, president and CEO of Gentell, announced that the company has purchased certain traditional and advanced wound care products and dressings from Integra LifeSciences, a leading global medical technology company. Integra LifeSciences will retain its MediHoney® and TCC-EZ® some products.

The transaction closed on August 31, 2022.

The Gentell purchase includes Integra LifeSciences’ manufacturing facilities in Toronto, Canada, and Nantong, China, as well as manufacturing assets in Morelos, Mexico. In addition, Gentell will maintain ongoing wound care manufacturing relationships with major hospital and nursing home distributors and manufacture MediHoney® and TCC-EZ® produced on behalf of Integra at the Toronto plant.

With the acquisition of Integra LifeSciences traditional wound care products such as sponges, gauze and conformation bandages and advanced wound care dressings such as support dressings, calcium alginate, hydrogel and foam, Gentell will become one of the largest manufacturers of wound care products and dressings in North America. Already a leader in providing wound care to the nursing home and assisted living market, Gentell intends to capitalize on its additional capacity to expand its presence in the hospital, home care and palliative care markets. , among others.

Navazio said, “Wounds will not wait for supply chain issues. Gentell purchased these products to reinforce our global “growth platform” strategy. This opportunity for vertical integration enhances our ability to control our destiny and provide comfort, quality and care to the tens of thousands of patients we serve.

With the addition of nearly 100,000 square feet of manufacturing space in Toronto as well as its own 55,000 square foot warehouse, Gentell plans to expand its presence in Canada, as well as more efficiently provide growth and development international. Distribution will originate from Gentell’s six warehouse distribution centers strategically located across North America.

Gentell also plans to strengthen its new product development efforts at the Toronto plant. Navazio said, “We know there is still room for innovation in wound care products, and we are excited to engage this team in this effort. We are positioned to lead the industry in investment in wound care R&D, reinforcing our brand as a global provider of state-of-the-art wound care.

Gentell plans to celebrate its acquisition with a ribbon-cutting ceremony at the Toronto manufacturing facility on September 1.

Navazio said, “We welcome our Canadian and Chinese team, partners and customers to the Gentell family. Together, we are working to ensure that advanced wound care is available effectively and affordably, and in the event of the next pandemic, there will be no shortage of wound care.

Along with the investor support, Regions Bank provided a financial package to support the acquisition.


Gentell is one of the largest manufacturers of wound care dressings in North America, with manufacturing plants in the United States, Canada and China, as well as facilities around the world. The company manufactures and supplies effective and affordable patient-specific wound care treatments to nursing homes, hospitals, home care, hospices and other providers. Gentell is renowned for innovating its “Total Wound Care Solution” which includes: 1) its comprehensive line of advanced wound care products, 2) on-site clinical consultants, 3) proprietary wound management system specific to the patient called Gentell Fastcare and 4) Wound Advisor wound care protocol development. The company, headquartered in the Philadelphia metro area, was founded in 1994 by industry thought leader David Navazio. Edward Quilty, former CEO of Derma Sciences, is an advisor and board member of Gentell.

2701 Bartram Road
Bristol, Pennsylvania 19007 USA
Toll Free: 1-800-840-9041
Phone: 215-788-2700
Fax: 215-788-2715

LinkedIn: /company/gentell
Twitter: @gentell 2701

# # #

Valerie Falkenberg
+1 800-840-9041
[email protected]

About Thomas Hereford

Check Also

Indian health tech startup CureBay secures $6m Series A funding

Indian digital health startup CureBay has raised INR 50 million ($6 million) in a Series …